- WORLD EDITIONAustraliaNorth AmericaWorld
Investing News NetworkYour trusted source for investing success
- Lithium Outlook
- Oil and Gas Outlook
- Gold Outlook Report
- Uranium Outlook
- Rare Earths Outlook
- All Outlook Reports
- Top Generative AI Stocks
- Top EV Stocks
- Biggest AI Companies
- Biggest Blockchain Stocks
- Biggest Cryptocurrency-mining Stocks
- Biggest Cybersecurity Companies
- Biggest Robotics Companies
- Biggest Social Media Companies
- Biggest Technology ETFs
- Artificial Intellgience ETFs
- Robotics ETFs
- Canadian Cryptocurrency ETFs
- Artificial Intelligence Outlook
- EV Outlook
- Cleantech Outlook
- Crypto Outlook
- Tech Outlook
- All Market Outlook Reports
- Cannabis Weekly Round-Up
- Top Alzheimer's Treatment Stocks
- Top Biotech Stocks
- Top Plant-based Food Stocks
- Biggest Cannabis Stocks
- Biggest Pharma Stocks
- Longevity Stocks to Watch
- Psychedelics Stocks to Watch
- Top Cobalt Stocks
- Small Biotech ETFs to Watch
- Top Life Science ETFs
- Biggest Pharmaceutical ETFs
- Life Science Outlook
- Biotech Outlook
- Cannabis Outlook
- Pharma Outlook
- Psychedelics Outlook
- All Market Outlook Reports
Faircourt Asset Management President and CEO Charles Taerk discussed NanoSphere Health Sciences (CSE:NSHS) with BNN Bloomberg. Nanosphere is a nano-biotechnology company focused on providing next generation delivery of nutritive elements and medication. Taerk talked about how Nanosphere’s technology breaks down cannabis oils, which are very thick and not easily digestible, to increase their bioavailability and ensure that patients receive fast relief for their symptoms.
Faircourt Asset Management President and CEO Charles Taerk discussed NanoSphere Health Sciences (CSE:NSHS) with BNN Bloomberg in an interview with the publication. Nanosphere is a nano-biotechnology company focused on providing next generation delivery of nutritive elements and medication. Taerk talked about how Nanosphere’s technology breaks down cannabis oils, which are very thick and not easily digestible. The technology helps increase their bioavailability and ensure that patients receive fast relief for their symptoms.
While Taerk believes that Nanosphere has hit some important milestones and breakthroughs with their technology, he believes the company has more work to do. His view is that Nanosphere’s next step will be to develop an odorless, tasteless and colourless formulation that can be applied to beverages. He pointed out that most people want to buy a drink that is like every other on the market, while still accessing the benefits associated with cannabis.
To watch the full interview, click here.
Click here to connect with NanoSphere Health Sciences (CSE:NSHS) for an Investor Presentation.
Source: www.bnnbloomberg.ca
Latest News
Investing News Network websites or approved third-party tools use cookies. Please refer to the cookie policy for collected data, privacy and GDPR compliance. By continuing to browse the site, you agree to our use of cookies.